Latest article
Sort-2 diabetes emerges as outstanding post-Covid symptom
Even as the world recovers from the second wave of pandemics, post-Covid symptoms are cause for concern among recovered patients. Among the health...
Tandem Diabetes Care (NASDAQ:TNDM) PT Lowered to $95.00 at SVB Leerink
Tandem Diabetes Care (NASDAQ: TNDM) The price target was lowered from USD 115.00 to USD 95.00 by analysts at SVB Leerink in a research...
